Novo Nordisk Navigates Pricing Pressures with Strategic Pivot
Novo Nordisk slashes prices in some markets and launches Wegovy subscriptions as new clinical data shows edge over…
Novo Nordisk Navigates Pricing Pressures with Strategic Pivot
Novo Nordisk slashes prices in some markets and launches Wegovy subscriptions as new clinical data shows edge over…
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk
Hims & Hers settles patent litigation, will now sell Novo Nordisk’s Ozempic and Wegovy. The telehealth firm forecasts…
Hims & Hers Stock Soars on Strategic Pivot and Novo Nordisk Alliance
Hims & Hers partners with Novo Nordisk for FDA-approved GLP-1 drugs, resolving legal risks and fueling a 40%…
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk
Hims & Hers abandons compounding for a direct Novo Nordisk deal, restoring access to Wegovy and sending its…